Contribution of Potentially Inappropriate Medications to Polypharmacy-Associated Risk of Mortality in Middle-Aged Patients: A National Cohort Study-Reference-Cited by-同舟云学术

Contribution of Potentially Inappropriate Medications to Polypharmacy-Associated Risk of Mortality in Middle-Aged Patients: A National Cohort Study

Published:2024-06-03 Issue: Volume: Page:
ISSN:0884-8734
Container-title:Journal of General Internal Medicine
language:en
Short-container-title:J GEN INTERN MED

Author:

Guillot Jordan^ORCID,Justice Amy C.,Gordon Kirsha S.,Skanderson Melissa,Pariente Antoine,Bezin Julien,Rentsch Christopher T.

Funder

National Institute on Alcohol Abuse and Alcoholism

Fulbright Association

Académie française

Center of Excellence in Regulatory Science and Innovation

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11606-024-08817-4.pdf

Reference66 articles.

1. Monégat M, Sermet C, Perronnin M, Rococo E. Polypharmacy: definitions, measurement and stakes involved - review of the literature and measurement tests. Quest d’économie la Santé 2014;204:1–8.

2. WHO Centre for Health Development (‎Kobe, Japan)‎. A glossary of terms for community health care and services for older persons. Kobe, Japan : WHO Centre for Health Development. 2004. http://www.who.int/iris/handle/10665/68896

3. Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. JAMA. 2015 Nov 3;314(17):1818–30.

4. Nishtala PS, Salahudeen MS. Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005–2013. Gerontology. 2015;61(3):195–202.

5. Jyrkkä J, Enlund H, Lavikainen P, Sulkava R, Hartikainen S. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf. 2011 May;20(5):514–22.